BTSG vs OPCH
BTSG: BrightSpring Health Services provides integrated pharmacy and clinical care solutions specifically tailored for complex, high-needs patient populations in home and community settings. OPCH: Option Care Health is a national leader in home and alternate site infusion services, providing essential, complex clinical care to patients outside of hospital settings.
Side-by-side fundamentals
| Metric | BTSG | OPCH | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $62.42 | $31.36 | |
| Market cap | $12.4B | $4.7B | |
| P/E as of 2026-10-20 | 37.83 | 24.50 | OPCH lower |
| PEG as of 2026-10-20, 3-year EPS CAGR to FY2025 | n/a | 1.61 | |
| Net margin FY2025, SEC XBRL | +1.5% | +3.7% | OPCH higher |
| Gross margin FY2025, SEC XBRL | +11.8% | +19.3% | OPCH higher |
| Operating margin FY2025, SEC XBRL | +2.3% | +6.0% | OPCH higher |
| ROE FY2025, SEC XBRL | +10.2% | +15.7% | OPCH higher |
| ROA FY2025, SEC XBRL | +3.0% | +6.0% | OPCH higher |
| Debt / equity | 1.07 | 0.86 | OPCH lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +28.2% | +13.0% | BTSG higher |
| Revenue CAGR (3y) SEC XBRL | +18.7% | +13.4% | BTSG higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 1.18 | 0.33 | |
| 1-year return as of 2026-10-20 close | +104.9% | +10.5% | BTSG higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.